These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28381104)

  • 1. Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysis.
    Lin J; Li C; Zhang C; Shi F; Wang H
    Future Oncol; 2017 Jul; 13(16):1395-1404. PubMed ID: 28381104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
    Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
    Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
    Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmastectomy radiation therapy in T3 node-negative breast cancer.
    Elmore L; Deshpande A; Daly M; Margenthaler JA
    J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
    Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
    Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
    Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
    Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
    Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 17. Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
    Zhang N; Zhang J; Zhang H; Liu Y; Zhao W; Wang L; Chen B; Moran MS; Haffty BG; Yang Q
    Oncologist; 2019 Dec; 24(12):e1286-e1293. PubMed ID: 31315963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.